Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-019901
Filing Date
2018-01-25
Accepted
2018-01-25 17:13:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d515670d424b5.htm 424B5 543873
2 GRAPHIC g515670g35x79.jpg GRAPHIC 41364
3 GRAPHIC g515670g36l01.jpg GRAPHIC 20038
4 GRAPHIC g515670g48h43.jpg GRAPHIC 62439
  Complete submission text file 0001193125-18-019901.txt   715905
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-210585 | Film No.: 18549057
SIC: 2834 Pharmaceutical Preparations